PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-87.96%
Both yoy net incomes decline, with SUM at -2345.33%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
7.30%
Less D&A growth vs. SUM's 76.36%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-100.97%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-4.76%
Negative yoy SBC while SUM is 28.98%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-464.98%
Both reduce yoy usage, with SUM at -163.02%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-434.04%
Both yoy AR lines negative, with SUM at -111.56%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-443.95%
Both reduce yoy inventory, with SUM at -119.45%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-1952.85%
Negative yoy AP while SUM is 149.02%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-9.89%
Both reduce yoy usage, with SUM at -343.16%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-33.77%
Negative yoy while SUM is 1535.65%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-135.43%
Both yoy CFO lines are negative, with SUM at -129.37%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
3.25%
Some CapEx rise while SUM is negative at -8.83%. John Neff would see competitor possibly building capacity while we hold back expansions.
-940.57%
Both yoy lines negative, with SUM at -1555.38%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-142.62%
Negative yoy purchasing while SUM stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
We reduce yoy sales while SUM is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-828.00%
We reduce yoy other investing while SUM is 19.22%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-182.29%
Both yoy lines negative, with SUM at -23218.28%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-37.70%
We cut debt repayment yoy while SUM is 36.78%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
100.00%
Lower share issuance yoy vs. SUM's 339.26%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
46.04%
Buyback growth of 46.04% while SUM is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.